Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2026

Cash Increased Sequentially by $468,000 to $18 Million

Plans to Achieve Cash Flow Positive in Second Half of Calendar Year 2026

Business Stabilized Following Strategic Repositioning

Phased Roadmap Targets Billions in Addressable Market, Including ~$73B Global Vape, ~$50–70B U.S. Flavored Vape, and $24B+ Global G-Mesh Glass Technology

LOS ANGELES, May 7, 2026 /PRNewswire/ -- Ispire Technology Inc. (Nasdaq: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the third quarter of fiscal 2026, for the three months ended March 31, 2026.

Ispire

Michael Wang, Co-Chief Executive Officer of Ispire, commented, "This quarter reflects the successful stabilization of our business and with cash growing sequentially by $468,000 to $18 million, we are now executing against a phased roadmap, with near-term revenue drivers already in production and transformative technology opportunities on the horizon:

  • Our Malaysia manufacturing is live today, giving us a 25% tariff advantage over China in a ~$73B global vape market.
    • Supply of nicotine pouches to global customers commenced in April 2026.
  • Vapor ODM launches in July 2026 for mid-sized brands, with large brand partnerships targeted for 2027.
  • Looking further ahead (2027 and beyond):
    • Age-gating technology through IKE Tech has the potential to unlock the ~$50–70B US flavored vape market
    • G-Mesh glass technology is already drawing interest from big tobacco in a $24B+ legal global market.

"With cash generation this quarter and proprietary technologies in age-gating and G-Mesh that no competitor can replicate, we have multiple shots on goal across billion-dollar markets, and we believe Ispire is uniquely positioned to deliver outsized value for shareholders."

Multiple Growth Catalysts, Each Backed by a Massive Addressable Market

Catalyst

Timeline

Opportunity

Malaysia

Manufacturing

Now

~$73B global vape market; 25% tariff advantage over

China

Vapor ODM

July 2026 /

2027

Mid-sized brands in 2026; large brand partnerships in

2027

Age-Gating (IKE

Tech)

2027+

~$50-70B US flavored vape market currently locked;

~6B devices/year US TAM

G-Mesh Technology

2027+

$24B+ legal global vape market; licensing discussions

with big tobacco underway

Financial Results for the Fiscal Third Quarter Ended March 31, 2026

  • Revenue was $18.7 million, compared to $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior sequential quarter. The sequential decline of $1.6 million, or 8%, represents the smallest second-to-third quarter decline in the Company's history, reflecting the typical seasonal impact of Chinese New Year-related factory shutdowns. The year-over-year decline reflects the Company's continued strategic shift away from lower-quality cannabis revenue toward regulated nicotine delivery and compliance technologies. Overall, the business continues to stabilize.
  • Gross profit of $2.0 million compared to $4.8 million for the third quarter of fiscal 2025 and $3.5 million in the prior sequential quarter. Gross margin was impacted by approximately $2.2 million in one-time product returns from legacy cannabis customers with whom the Company has ceased doing business. Gross margin of 10.7% compared to 18.2% for the third quarter of fiscal 2025, is primarily attributable to the approximately $2.2 million one-time product returns from legacy cannabis customers with whom the Company has ceased doing business.
  • Total operating expenses excluding bad debt expense of $5.9 million, a 36% reduction when compared to operating expenses of $9.3 million for the third quarter of fiscal 2025, and a 3.7% reduction when compared to operating expenses of $6.1 million in the prior sequential quarter. Bad debt expense was $5.6 million, which is $0.5 million less than the third quarter of fiscal 2025 and $1.4 million more than the prior quarter.
  • Net loss of $9.5 million or ($0.17) per share, a 12.3% decrease, compared to net loss of $10.9 million, or ($0.19) per share, in the third quarter of fiscal 2025, and a 44.4% increase compared a net loss of $6.6 million in the prior sequential quarter.
  • Cash: At March 31, 2026, the Company held cash of $18.0 million and working capital of $0.9 million.

Conference Call

The Company will conduct a conference call at 8 am ET on Friday, May 7, 2026, to discuss the results, followed by a Q&A session.

To listen to the conference call, please dial in using the information below. When prompted upon dialing-in, please ask for the "Ispire Technology Call."

  • Date: Thursday, May 7, 2026
  • Time: 8:00 am ET
  • Dial-In Numbers: United States 844-826-3033 or International + 1-412-317-5185

This conference call will be webcast live and can be accessed by all interested parties at https://viavid.webcasts.com/starthere.jsp?ei=1761477&tp_key=3958311007

Please access the link at least fifteen minutes prior to the start of the call to register, download, and install any necessary audio software.

A playback will be available until 11:59 pm ET on Friday, May 21, 2026. To listen, please dial 1-844-512-2921 or 1-412-317-6671. Use the passcode 10208863 to access the replay.

About Ispire Technology Inc.

Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company's cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information visit www.ispiretechnology.com or follow Inspire on Instagram, LinkedIn, Twitter and YouTube.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: whether the Company may be successful in re-entering the U.S. ENDS market; the approval or rejection of any PMTA submitted by the Company; whether the Company will be successful in its plans to further expand into the African market; whether the Company's joint venture with Touch Point Worldwide Inc. d/b/a/ Berify and Chemular Inc. (the "Joint Venture") may be successful in achieving its goals as currently contemplated, with different terms, or at all; the Joint Venture's ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices; the Company's ability to collect its accounts receivable in a timely manner; the Company's business strategies; the ability of the Company to market to the Ispire ONE™; Ispire ONE™'s success in meeting its goals; the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of its products on the markets; the Ispire ONE™ proving to be safe; and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2025 and any subsequent filings which Ispire makes with the SEC. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by applicable law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

Contact:

HAYDEN IR:

James Carbonara

(646)-755-7412

james@haydenir.com

Brett Maas

(646) 536-7331

brett@haydenir.com

-- Tables Follow –

ISPIRE TECHNOLOGY INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In $USD, except share and per share data)











March 31,

2026





June 30,

2025



Assets













Current assets:













Cash



$

18,033,652





$

24,351,765



Restricted cash





50,000







-



Accounts receivable, net





28,651,558







39,664,145



Inventories





5,480,044







6,647,970



Prepaid expenses and other current assets





3,523,741







2,244,505



Total current assets





55,738,995







72,908,385



Non-current assets:

















Accounts receivable, net of current portion





-







7,367,158



Property, plant and equipment, net





2,665,534







2,952,800



Intangible assets, net





2,601,408







2,232,620



Right-of-use assets – operating leases





3,855,373







5,030,005



Other investment





2,000,000







2,000,000



Equity method investment





8,839,130







9,515,546



Other non-current assets





210,617







210,617



Total non-current assets





20,172,062







29,308,746



Total assets



$

75,911,057





$

102,217,131



Liabilities and stockholders' (deficit)/equity

















Current liabilities

















Accounts payable



$

5,005,033





$

4,172,476



Accounts payable – related party





38,159,288







52,420,256



Contract liabilities





3,043,470







4,861,250



Accrued liabilities and other payables





6,003,509







8,099,991



Borrowing – current portion





1,092,052







1,146,766



Operating lease liabilities – current portion





1,546,770







1,838,815



Total current liabilities





54,850,122







72,539,554





















Non-current liabilities:

















Amount due to a related party





35,000,000







25,000,000



Borrowing – net of current portion





-







805,361



Operating lease liabilities – net of current portion





2,265,347







3,267,522



Total non-current liabilities





37,265,347







29,072,883



Total liabilities





92,115,469







101,612,437





















Commitments and contingencies



































Stockholders' (deficit)/equity:

















Common stock, par value $0.0001 per share; 140,000,000 shares authorized;

57,399,396 and 57,193,734 shares issued and outstanding as of March 31, 2026

and June 30, 2025





5,740







5,719



Treasury stock, at cost





(60,488)







(60,488)



Additional paid-in capital





51,541,046







48,833,601



Accumulated deficit





(67,450,024)







(48,065,267)



Accumulated other comprehensive loss





(240,686)







(108,871)



Total stockholders' (deficit)/equity





(16,204,412)







604,694



Total liabilities and stockholders' (deficit)/equity



$

75,911,057





$

102,217,131



ISPIRE TECHNOLOGY INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND

COMPREHENSIVE LOSS

(In $USD, except share and per share data)







Three Months Ended

March 31,





Nine Months Ended

March 31,







2026





2025





2026





2025





























Revenue



$

18,685,501





$

26,190,725





$

69,322,941





$

107,356,898





































Cost of revenue





16,694,576







21,414,820







58,710,643







87,184,044





































Gross profit





1,990,925







4,775,905







10,612,298







20,172,854





































Operating expenses:

































Sales and marketing expenses





1,091,907







1,656,527







4,133,079







6,710,438



Credit loss expenses





5,564,497







6,103,688







11,537,950







13,389,767



General and administrative expenses





4,818,256







7,601,131







13,995,180







23,281,014





































Total Operating expenses





11,474,660







15,361,346







29,666,209







43,381,219





































Loss from operations





(9,483,735)







(10,585,441)







(19,053,911)







(23,208,365)





































Other income (expense):

































Interest income





52,971







3,480







253,365







63,321



Interest expense





(87,215)







(35,646)







(299,582)







(60,183)



Exchange (loss) gain, net





(30,294)







24,341







269,745







(103,247)



Other income (expense), net





202,697







(86,239)







215,688







(47,906)





































Total Other income (expense), net





138,159







(94,064)







439,216







(148,015)





































Loss before income taxes





(9,345,576)







(10,679,505)







(18,614,695)







(23,356,380)





































Income taxes





(177,407)







(176,990)







(770,062)







(1,093,774)





































Net loss



$

(9,522,983)





$

(10,856,495)





$

(19,384,757)





$

(24,450,154)





































Other comprehensive loss

































Foreign currency translation adjustments





(10,490)







(2,860)







(131,815)







(84,327)



Comprehensive loss



$

(9,533,473)





$

(10,859,355)





$

(19,516,572)





$

(24,534,481)





































Net loss per share

































Basic and diluted



$

(0.17)





$

(0.19)





$

(0.34)





$

(0.43)





































Weighted average shares outstanding:

































Basic and diluted





57,293,826







57,003,488







57,269,726







56,752,454



ISPIRE TECHNOLOGY INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In $USD, except share and per share data)







Nine Months Ended

March 31,







2026





2025

















Net loss



$

(19,384,757)





$

(24,450,154)



Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:

















Depreciation and amortization





691,894







592,280



Credit loss expenses





11,537,950







13,389,767



Right-of-use assets amortization





1,172,118







1,001,101



Stock-based compensation expenses





2,752,467







4,923,751



Inventory impairment





2,386,751







73,692



Loss from equity method investment





676,416







407,028



Debt issuance cost amortization





96,937







-



Changes in operating assets and liabilities:

















Accounts receivable





6,841,795







(14,080,837)



Inventories





(1,218,825)







(1,485,433)



Prepaid expenses and other current assets





(1,332,448)







(715,969)



Accounts payable and accounts payable – related party





(3,428,411)







10,962,439



Contract liabilities





(1,817,780)







(756,872)



Accrued liabilities and other payables





(876,774)







(969,068)



Operating lease liabilities





(1,291,706)







(961,244)



Net cash used in operating activities





(3,194,373)







(12,069,519)





















Cash flows from investing activities:

















Purchase of property, plant and equipment





(324,225)







(140,956)



Capitalized costs for patents





(449,191)







(781,254)



Investment in joint venture





(1,298,311)







(767,285)



Net cash used in investing activities





(2,071,727)







(1,689,495)





















Cash flows from financing activities:

















Common stock repurchase





(45,001)







(60,488)



Proceeds from long term debt





-







2,339,362



Repayment of borrowing





(957,012)







-



Net cash (used in)/provided by financing activities





(1,002,013)







2,278,874





















Net decrease in cash





(6,268,113)







(11,480,140)



Cash – beginning of period





24,351,765







35,071,294



Cash and restricted cash– end of period



$

18,083,652





$

23,591,154



Reconciliation of cash and restricted cash

















Cash





18,033,652







23,518,560



Restricted cash





50,000







72,594



Total cash and restricted cash



$

18,083,652





$

23,591,154



Supplemental non-cash investing and financing activities

















Reclassification of accounts receivable – noncurrent to accounts receivable



$

6,934,364





$

-



Reclassification of accounts payable – related party to amount due to a related party



$

10,000,000





$

-



Leased assets obtained in exchange for operating lease liabilities



$

-





$

2,771,082



Unpaid long term investment in accrued liabilities and other payables



$

-





$

8,232,715



Supplemental disclosures

















Cash paid for income taxes



$

1,614,273





$

1,413,533



Cash paid for interest



$

299,582





$

60,183



ISPIRE TECHNOLOGY INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In $USD, except share and per share data)





Three Months Ended



March 31,



2026





2025

Net loss

$ (9,522,983)





$ (10,856,495)

Adjustments to reconcile net loss to net cash -used in/provided by operating

activities:

$ -





$ -

Depreciation and amortization

$ 210,652





$ 198,955

Credit loss expenses

$ 5,564,497





$ 6,103,688

Right-of-use assets amortization

$ 479,982





$ 371,717

Stock-based compensation expenses

$ 992,478





$ 1,470,877

Inventory impairment

$ 849,313





$ -

Loss from equity method investment

$ 290,083





$ 230,360

Debt issuance cost amortization

$ 32,312





$ -

Changes in operating assets and liabilities:

$ -





$ -

Accounts receivable

$ 3,662,298





$ 1,170,940

Inventories

$ (1,291,943)





$ 181,075

Prepaid expenses and other current assets

$ (363,641)





$ 139,686

Accounts payable and accounts payable – related party

$ 3,582,462





$ (9,743,313)

Contract liabilities

$ (1,927,665)





$ (549,992)

Accrued liabilities and other payables

$ (99,500)





$ (838,174)

Operating lease liabilities

$ (489,737)





$ (376,953)

Income tax payable

$ (12,590)





$ -

Net cash provided by operating activities

$ 1,956,018





$ (12,497,629)



$ -







Cash flows from investing activities:

$ -







Purchase of property, plant and equipment

$ (247,347)





$ 181,808

Capitalized costs for patents

$ (156,349)





$ -

Investment in joint venture

$ (765,000)





$ (767,285)

Net cash used in investing activities

$ (1,168,696)





$ (585,477)



$ -







Cash flows from financing activities:

$ -







Common stock repurchase

$ -





$ (60,488)

Proceeds from long term debt

$ -





$ 2,339,362

Repayment of borrowing

$ (319,004)





$ -

Net cash used in financing activities

$ (319,004)





$ 2,278,874



$ -







Net increase in cash

$ 468,318





$ (10,804,232)

Cash – beginning of period

$ 17,615,334





$ 34,395,386

Cash and restricted cash– end of period

$ 18,083,652





$ 23,591,154

Reconciliation of cash and restricted cash









Cash

$ 18,033,652





$ 23,518,560

Restricted cash

$ 50,000





$ 72,594

Total cash and restricted cash

$ 18,083,652





$ 23,591,154

Supplemental non-cash investing and financing activities









Reclassification of accounts receivable – noncurrent to accounts receivable

$ -





$ -

Reclassification of accounts payable – related party to amount due to a

related party

$ 6,000,000





$ -

Leased assets obtained in exchange for operating lease liabilities

$ -





$ 2,771,082

Unpaid long term investment in accrued liabilities and other payables

$ -





$ 8,232,715

Supplemental disclosures

$ -





$ -

Cash paid for income taxes

$ 3,081 -





$ -

Cash paid for interest

$ 87,215





$ 35,646

Cision View original content:https://www.prnewswire.com/apac/news-releases/ispire-technology-inc-reports-financial-results-for-fiscal-third-quarter-2026-302764937.html

SOURCE Ispire Technology Inc.